This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Nov;12(11):735.

doi: 10.1038/nrc3390.

Angiogenesis: A deeper understanding of VEGFR inhibitors

Charlotte Harrison

PMID: 23090026
DOI: 10.1038/nrc3390

Comment

Angiogenesis: A deeper understanding of VEGFR inhibitors

Charlotte Harrison. Nat Rev Cancer. 2012 Nov.

. 2012 Nov;12(11):735.

doi: 10.1038/nrc3390.

Author

Charlotte Harrison

PMID: 23090026
DOI: 10.1038/nrc3390

No abstract available

PubMed Disclaimer

Republished from

Anticancer drugs: A deeper understanding of VEGFR inhibitors.
Harrison C. Harrison C. Nat Rev Drug Discov. 2012 Nov;11(11):831. doi: 10.1038/nrd3873. Epub 2012 Oct 12. Nat Rev Drug Discov. 2012. PMID: 23060264 No abstract available.

Comment on

Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors.
McTigue M, Murray BW, Chen JH, Deng YL, Solowiej J, Kania RS. McTigue M, et al. Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18281-9. doi: 10.1073/pnas.1207759109. Epub 2012 Sep 17. Proc Natl Acad Sci U S A. 2012. PMID: 22988103 Free PMC article.

References

1. Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18281-9 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group